Autoimmune Disease Market Size, Share & Segmentation By Product (Consumables and Assay Kits Instruments ),By Test type (Laboratory Tests, Inflammatory Markers Autoantibodies & Immunologic tests ), By Disease Type(Systematic Autoimmune Disease, Localize Autoimmune Disease) By End User (Clinical Laboratories, Hospitals)
Report Id: SNS/HC/2666 | January 2023 | Region: Global | 130 Pages
Report scope & Overview
Autoimmune Disease Market was valued at USD 1099 million in 2022 and is expected to reach USD 1791 million by 2030, and grow at a CAGR of 6.3% over the forecast period of 2023-2030. The autoimmune disease global market is expected to grow because of the rise in awareness of this disease, in autoimmune disease the production of antibodies tends to happen which attacks its healthy tissues. Experts say that during autoimmune disease the immune system fails to detect abnormality in the tissues or any other part of the body, abnormality in the functioning of the immune system is the biggest concerning factor. There is no proper information about what triggers autoimmune diseases so genes are one of the main reasons behind the cause of autoimmune diseases. In autoimmune disease, the healthy tissues can’t predict the difference between the healthy tissues and the tissues which are unhealthy or let’s say which don’t deserve to be the in the body which results in the attack on healthy cells which leads to many issues and severe health concerns.
Impact of covid 19
As we all know covid 19 affected each and every industry due to major issues like the strict rules imposed by the government. Covid 19 had a negative impact on the Autoimmune disease global market. The reasons include the disruption of supply chain management all around the globe as resources were not available which led to stop in production, and due to the fear of covid 19 patients didn’t visited hospitals on a regular basis, according to the data patients showed up to the hospital only in emergency cases. Also, the priority for the healthcare industry was to focus on covid patients which also had a negative impact on autoimmune disease global market.
Market Dynamics
Drivers
-
Rise in autoimmune diseases all around the globe
-
Increase of awareness in people for autoimmune diseases
Restrains
-
Unavailability of capital for setting up the diagnostic centers
Opportunity
-
Overall increase in technological advancement in the healthcare industry.
-
Support from the government for the autoimmune disease market and the favorable initiative taken by them.
Challenge
-
Time consumable process including test results
-
Uncertainty about the accuracy of results.
Impact of Russia Ukraine war
The Russia-Ukraine war had an overall negative impact on the healthcare industry, due to the conditions in that region it has become very hard for the investors to invest in that region and also nations economic conditions gets affected during such situations .Autoimmune disease market may get negatively affected due to infrastructure loss caused by war, The unavailability of products and materials important for the autoimmune disease market also may get affected due to the disruption of global supply chain route.
Impact of ongoing recession
Recession will have a negative impact on the autoimmune global disease market due to the economic conditions worldwide. Experts say that during recession people’s perception towards health change, as people will not focus on treating the disease at the early stage due to the hospital expense, and people ignore the small symptoms. The cases of emergency patients will increase compared to regular check-ups and the only reason behind that is the instability of economic conditions. Also, there will be fluctuation in prices due to the rise in prices of other factors which co-relate with autoimmune diseases market such as transportation, taxes, government regulations and many more .
Regional analysis
Reports declare that Europe has the largest market share for autoimmune disease global market,
The driving factors include the rise in the disease due to the unhealthy lifestyle, the rise in the increase of aged population which leads to issues like weak immune system.
Asia Pacific is also considered to the fastest-growing region after Europe in the autoimmune disease market.
By Product
-
Consumables and Assay Kits
-
Instruments
By Test Type
-
Laboratory Tests
-
Inflammatory Markers
-
Autoantibodies & Immunologic tests
By Disease Type
-
Systematic Autoimmune Disease
-
Localize Autoimmune Disease
By End User
-
Clinical Laboratories
-
Hospitals
.jpg)
Key Players
The major Key players are Siemens, Abbott, Thermos, Fisher Scientific, Danaher, Bio-Rad Laboratories, Grifols, Trinity Biotech Werfen, Kronus, Cambridge life Sciences Limited, HTG Molecular Diagnostics
Frequently Asked Questions (FAQ) :
What was the market size in 2022 for this market?
The market size for 2022 for this market is USD 1099 million.
What is the driving factor for autoimmune diseases market?
Rise in autoimmune diseases all around the globe
What are the major challenges for autoimmune disease market?
1. Time consumable process including test results
2. Uncertainty about the accuracy of results
What is the covid 19 impact on the autoimmune disease market?
Focus on covid patients during covid 19 had a negative impact on the autoimmune disease global market
Autoimmune disease market is divided into how many segments?
Autoimmune disease market is divided into 4 segments By Product Type, By Test Type, By Disease Type and By End User.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia War
4.3 Impact of Current Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on Major Economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of The World
5. Value Chain Analysis
6. Porter’s 5 Forces Model
7. PEST Analysis
8.Autoimmune Disease Market Segmentation, By Product Type
8.1 Consumables and Assay Kits
8.2 Instruments
9.Autoimmune Disease Market Segmentation, By Test Type
9.1 Laboratory Tests
9.2 Inflammatory Markers
9.3 Autoantibodies & Immunologic Tests
10. Autoimmune Disease Market Segmentation, By Disease Type
10.1 Systematic Autoimmune Disease
10.2 Localize Autoimmune Disease
11 Autoimmune Disease Market Segmentation, By End User
11.1 Clinical Laboratories
11.2 Hospitals
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.1.1 USA Autoimmune Disease Market by Product Type
12.2.1.2 USA Autoimmune Disease Market by Test
12.2.1.2 USA Autoimmune Disease Market by Disease Type
12.2.1.3 USA Autoimmune Disease Market by End User
12.2.2 Canada
12.2.2.1 Canada Autoimmune Disease Market by Product Type
12.2.2.2 Canada Autoimmune Disease Market by Test Type
12.2.2.2 Canada Autoimmune Disease Market by Disease Type
12.2.2.3 Canada Autoimmune Disease Market by End User
12.2.3 Mexico
12.2.3.1 Mexico Autoimmune Disease Market by Product Type
12.2.2.2 Canada Autoimmune Disease Market by Test Type
12.2.3.3 Mexico Autoimmune Disease Market by Disease Type
12.2.3.4 Mexico Autoimmune Disease Market by End User
12.3 Europe
12.3.1 Germany
12.3.1.1 Germany Autoimmune Disease Market by Product Type
12.3.1.2 Germany Autoimmune Disease Market by Test Type
12.3.1.3 Germany Autoimmune Disease Market by Disease Type
12.3.1.4 Germany Autoimmune Disease Market by End User
12.3.2 UK
12.3.2.1 UK Autoimmune Disease Market by Product Type
12.3.2.2 UK Autoimmune Disease Market by Test Type
12.3.2.3 UK Autoimmune Disease Market by Disease Type
12.3.2.4 UK Autoimmune Disease Market by End User
12.3.3 France
12.3.3.1 France Autoimmune Disease Market by Product Type
12.3.3.2 France Autoimmune Disease Market by Test Type
12.3.3.3 France Autoimmune Disease Market by Disease Type
12.3.3.4 France Autoimmune Disease Market by End User
12.3.4 Italy
12.3.4.1 Italy Autoimmune Disease Market by Product Type
12.3.4.2 Italy Autoimmune Disease Market by Test Type
12.3.4.3 Italy Autoimmune Disease Market by Disease Type
12.3.4.4 Italy Autoimmune Disease Market by End User
12.3.5 Spain
12.3.5.1 Spain Autoimmune Disease Market by Product Type
12.3.5.2 Spain Autoimmune Disease Market by Test Type
12.3.5.3 Spain Autoimmune Disease Market by Disease Type
12.3.5.4 Spain Autoimmune Disease Market by End User
12.3.6 The Netherlands
12.3.6.1 Netherlands Autoimmune Disease Market by Product Type
12.3.6.2 Netherlands Autoimmune Disease Market by Test Type
12.3.6.3 Netherlands Autoimmune Disease Market by Disease Type
12.3.6.4 Netherlands Autoimmune Disease Market by End User
12.3.7 Rest of Europe
12.3.7.1 Rest of Europe Autoimmune Disease Market by Product Type
12.3.7.2 Rest of Europe Autoimmune Disease Market by Test Type
12.3.7.3 Rest of Europe Autoimmune Disease Market by Disease Type
12.3.7.4 Rest of Europe Autoimmune Disease Market by End User
12.4 Asia-Pacific
12.4.1 Japan
12.4.1.1 Japan Autoimmune Disease Market by Product Type
12.4.1.2 Japan Autoimmune Disease Market by Test Type
12.4.1.3 Japan Autoimmune Disease Market by Disease Type
12.4.1.4 Japan Autoimmune Disease Market by End User
12.4.2 South Korea
12.4.2.1 South Korea Autoimmune Disease Market by Product Type
12.4.2.2 South Korea Autoimmune Disease Market by Test Type
12.4.2.3 South Korea Autoimmune Disease Market by Disease Type
12.4.2.4 South Korea Autoimmune Disease Market by End User
12.4.3 China
12.4.3.1 China Autoimmune Disease Market by Product Type
12.4.3.2 China Autoimmune Disease Market by Test Type
12.4.3.3 China Autoimmune Disease Market by Disease Type
12.4.3.4 China Autoimmune Disease Market by End User
12.4.4 India
12.4.4.1 India Autoimmune Disease Market by Product Type
12.4.4.2 India Autoimmune Disease Market by Test Type
12.4.4.3 India Autoimmune Disease Market by Disease Type
12.5.4.4 India Autoimmune Disease Market by End User
12.4.5 Australia
12.4.5.1 Australia Autoimmune Disease Market by Product Type
12.4.5.2 Australia Autoimmune Disease Market by Test Type
12.4.5.3 Australia Autoimmune Disease Market by Disease Type
12.4.5.4 Australia Autoimmune Disease Market by End User
12.4.6 Rest of Asia-Pacific
12.4.6.1 APAC Autoimmune Disease Market by Product Type
12.4.6.2 APAC Autoimmune Disease Market by Test Type
12.4.6.3 APAC Autoimmune Disease Market by Disease Type
12.4.6.4 APAC Autoimmune Disease Market by End User
12.5 The Middle East & Africa
12.5.1 Israel
12.5.1.1 Israel Autoimmune Disease Market by Product Type
12.5.1.2 Israel Autoimmune Disease Market by Test Type
12.5.1.3 Israel Autoimmune Disease Market by Disease Type
12.5.1.4 Israel Autoimmune Disease Market by End User
12.5.2 UAE
12.5.2.1 UAE Autoimmune Disease Market by Product Type
12.5.2.2 UAE Autoimmune Disease Market by Test Type
12.5.2.3 UAE Autoimmune Disease Market by Disease Type
12.5.2.4 UAE Autoimmune Disease Market by End User
12.5.3 South Africa
12.5.3.1 South Africa Autoimmune Disease Market by Product Type
12.5.3.2 South Africa Autoimmune Disease Market by Test Type
12.5.3.3 South Africa Autoimmune Disease Market by Disease Type
12.5.3.4 South Africa Autoimmune Disease Market by End User
12.5.4 Rest of Middle East & Africa
12.5.4.1 Rest of Middle East & Asia Autoimmune Disease Market by Product Type
12.5.4.2 Rest of Middle East & Asia Autoimmune Disease Market by Test Type
12.5.4.3 Rest of Middle East & Asia Autoimmune Disease Market by Disease Type
12.5.4.4 Rest of Middle East & Asia Autoimmune Disease Market by End User
12.6 Latin America
11.6.1 Brazil
11.6.1.1 South Africa Autoimmune Disease Market by Product Type
12.6.1.2 South Africa Autoimmune Disease Market by Test Type
12.6.1.3 South Africa Autoimmune Disease Market by Disease Type
12.6.1.4 South Africa Autoimmune Disease Market by End User
11.6.2 Argentina
11.6.2.1 South Africa Autoimmune Disease Market by Product Type
12.6.2.2 South Africa Autoimmune Disease Market by Test Type
12.6.2.3 South Africa Autoimmune Disease Market by Disease Type
12.6.2.4 South Africa Autoimmune Disease Market by End User
12.6.3 Rest of Latin America
12.6.3.1 Mexico Autoimmune Disease Market by Product Type
12.6.3.2 Mexico Autoimmune Disease Market by Test Type
12.6.3.3 Mexico Autoimmune Disease Market by Disease Type
12.6.3.4 Mexico Autoimmune Disease Market by End User
13 Company Profile
13.1 Siemens
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Product/Services/Offerings
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Abbott
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Product/Services/Offerings
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Thermos Fisher Scientific
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Danaher
13.4.1 Market Overview
13.4.2 Financials
13.4.3 Product/Services/Offerings
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Bio Rad Laboratories
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Product/Services/Offerings
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Grifols
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Product/Services/Offerings
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Trinity Biotech
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Product/Services/Offerings
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Werven
13.8.1 Market Overview
13.8.2 Financials
13.8.3 Product/Services/Offerings
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Cronus
13.9.1 Market Overview
13.9.2 Financials
13.9.3 Product/Services/Offerings
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Cambridge Life Sciences Limited .
13.10.1 Market Overview
13.10.2 Financials
13.10.3 Product/Services/Offerings
13.10.4 SWOT Analysis
13.10.5 The SNS View
13.11 HTG Molecular Diagnostics
13.11.1 Market Overview
13.11.2 Financials
13.11.3 Product/Services/Offerings
13.11.4 SWOT Analysis
13.11.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
15 Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
